Inventor · disambiguated record
Anne Sadewasser
Also filed as: SADEWASSER ANNE
2 granted patents·2 pending applications·0 citations·filing 2019–2024
31Inventor score
Technology areasC12N
Top patents by PatentIndex Score
4 records- 0171US2024384272A1Angptl4 oligonucleotides influencing the regulation of the fatty acid metabolismLIPIGON PHARMACEUTICALS AB·Filed 2024·Application pending·0 cites
- 0266US11781139B2ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolismLIPIGON PHARMACEUTICALS AB·Filed 2022·Granted Oct 10, 2023·0 cites·13 claims
- 0361US12024708B2ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolismLIPIGON PHARMACEUTICALS AB·Filed 2019·Granted Jul 2, 2024·0 cites·18 claims
- 0446US2024067973A1Oligonucleotide for reducing the expression of angiotensin-converting enzyme 2 (ACE2) and its use for treating viral infectionTHE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anne Sadewasser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →